News

TMCnet37m
BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update
NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem ...
BrainStorm Reschedules First Quarter 2025 Financial Results Release to Post-Market Close Today and Sets Investor Call for Monday, May 19
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
Medical Device Network on MSN11h
FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC
The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.
T cells can sense testosterone—What does that mean for prostate cancer therapies?
The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...
Study finds common genetic target may halt breast cancer cell growth
Researchers from USask have identified a potential target for eliminating breast cancer cells. The team was led by Dr. Franco ...